Почетна › Рак простате › Mičigen › Detroit
Kliničke studije za Рак простате u gradu Detroit, MI
23 studija za Рак простате traži učesnike na lokacijama u gradu Detroit i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Тражи се учесник
- Wayne State University, Detroit
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
Тражи се учесник
- Henry Ford Health, Detroit
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Тражи се учесникФаза 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Тражи се учесникФаза 3
- Henry Ford Hospital, Detroit
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Тражи се учесникФаза 3
- Henry Ford Hospital ( Site 0035), Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Тражи се учесникФаза 3
- Henry Ford Hospital, Detroit
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 1/2
- Research Site, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 129, Detroit
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Тражи се учесникФаза 3
- Henry Ford Hospital ( Site 0015), Detroit
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Тражи се учесникФаза 3
- Research Site, Detroit
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Тражи се учесникФаза 3
- Karmanos Cancer Institute, Detroit
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Тражи се учесникФаза 1/2
- Karmanos Cancer Institute, Detroit
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Тражи се учесникФаза 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Тражи се учесникФаза 1
- Karmanos, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Тражи се учесник
- Karmanos Cancer Institute, Detroit
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Тражи се учесникОпсервациона студија
- Karmanos Cancer Institute, Detroit
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Тражи се учесникФаза 1/2
- Karmanos Cancer Institute, Detroit
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Тражи се учесникФаза 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Тражи се учесникФаза 3
- Henry Ford Health Saint John Hospital, Detroit
Studije za Рак простате u drugim gradovima
- New York City, NY101 студија
- Houston, TX73 студија
- Los Angeles, CA64 студија
- Boston, MA56 студија
- Seattle, WA45 студија
- St. Louis, MO45 студија
- Chicago, IL45 студија
- Baltimore, MD45 студија
- San Francisco, CA44 студија
- Philadelphia, PA41 студија
- Nashville, TN40 студија
- Washington, DC39 студија
Ostale studije u gradu Detroit
- Немалоклетни карцином плућа40 студија
- Рак дојке34 студија
- Рак јајника28 студија
- Рак (све врсте)27 студија
- Колоректални карцином25 студија
- Карцином ендометријума23 студија
- Метастатски карцином22 студија
- Рак плућа19 студија
- Многи мијелом19 студија
- Плоскоклеточни карцином главе и врата16 студија
- Рак желуца15 студија
- Затајење срца14 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.